Le Lézard
Classified in: Health
Subjects: LAW, PLW

Medit wins four consecutive patent lawsuits against 3Shape


SEOUL, South Korea, Oct. 7, 2022 /CNW/ -- Medit Corp. ("Medit"), a global provider of 3D scanning solutions, has successfully defended against four separate patent infringement actions filed in Germany by a Danish competitor, 3Shape A/S ("3Shape").  Over the past 3 years, 3Shape has aggressively pursued patent infringement actions against Medit based on four patents (EP 2,568,870; EP 2,400,919; EP 2,732,434; EP 3,401,876). However, all four patent lawsuits have now been concluded in Medit's favor by German courts. Moreover, 1 of the 4 patents were invalidated by German courts.

"We are delighted to find that the court confirmed these cases were without merit and also it was an attempt by the competitor to protect its preemptive position. We hope that this result helps discourage reckless legal disputes in the future. We see this as a victory for our customers and partners, and ultimately all those interested in digital dentistry. These rulings offer digital dentistry market a greater clarity and much needed security.  Medit will continue to bring the best technology for the benefit of our customers and the patients." <GB Ko, CEO> 

SOURCE Medit


These press releases may also interest you

at 18:45
Kerecis, the pioneer in the use of fish skin and fatty acids for tissue regeneration and protection, will unveil its latest scientific and clinical updates, including trial results, at the upcoming Symposium on Advanced Wound Care (SAWC) Spring. The...

at 18:38
Actinium Pharmaceuticals, Inc. ...

at 18:26
StretchMed, a leading innovator in the health & wellness industry, is thrilled to announce its upcoming Regulation Crowdfunding (REG CF) raise in partnership with Republic, the prominent investment platform democratizing access to investments in...

at 18:01
New research, presented today at the 10th European Stroke Organisation Conference (ESOC) 2024, has revealed that high-income individuals have a 32% lower risk of post-stroke mortality. Additionally, those with a higher education have a 26% lower risk...

at 18:00
Aeterna Zentaris Inc. ("Aeterna" or the "Company"), a specialty biopharmaceutical company...

at 18:00
Sojitz, a large Japanese general trading company with extensive networks within the Japanese bioeconomy, and Ginkgo Bioworks , which is building the leading platform for cell programming and biosecurity, today announced that they have entered into a...



News published on and distributed by: